CLSD - Clearside Biomedical, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue345520--
Cost of Revenue----
Gross Profit345520--
Operating Expenses
Research Development49,05319,45510,7626,692
Selling General and Administrative9,7006,2636,5553,131
Non Recurring----
Total Operating Expenses58,75325,71817,3179,823
Operating Income or Loss-58,408-25,198-17,317-9,823
Income from Continuing Operations
Total Other Income/Expenses Net-567-684-322-366
Earnings Before Interest and Taxes-58,408-25,198-17,317-9,823
Interest Expense-926-587-223.4-400
Income Before Tax-58,975-25,882-17,639-10,189
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-58,975-25,882-17,639-10,189
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-58,975-25,882-17,639-10,189
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-58,975-25,882-17,639-10,189